Got feedback on the new design? We're Listening! Send us Feedback

First Pharmaceutical Drug To Improve Survival Amongst Patients With Advanced Hepatocarcinoma »

Posted by: dirtyfratboy 2 months ago

0 Comments Report this Story

1.0

Scale of 1 to 10

Read: 4

Propped: 8

Comments: 0

Click Prop It to Raise Score
Prop it

International research involving the University Hospital of the University of Navarra, together with other hospitals in Spain, has shown that Sorafenib, an orally administered pharmaceutical medicine, results in patients with primary hepatocarcinomas (liver tumours) to live 40% more on average compared to those not taking the drug.

Read Full Story at sciencedaily.com

Join the Discussion

+ Add Comment
Comments So Far: 0

You must be signed in to post a comment. Sign in »

Submitted By:
dirtyfratboy

Hey all, I'm Henry. I'm a student right now and I'll be majoring in Business at the University of Illinois Urbana-Champaign. During ...

Related Articles:

Why not submit a story?

Also Propping This Article

view all »

Groups Watching This

No groups are watching this story. Why not share it with your group?

Advertisement